Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Swen Hoelder is active.

Publication


Featured researches published by Swen Hoelder.


Archive | 2003

Pyridazinone derivatives as gsk-3beta inhibitors

Swen Hoelder; Thorsten Naumann; Karl Schoenafinger; David William Will; Hans Matter; Guenter Mueller; Suisse Dominique Le; Bernard Baudoin; Thomas Rooney; Franck Halley; Gilles Tiraboschi


Archive | 2006

4-BENZIMIDAZOL-2-YL-PYRIDAZINE-3-ONE-DERIVATIVES, PRODUCTION AND USE THEREOF IN MEDICAMENTS

Karl Schoenafinger; Swen Hoelder; David William Will; Hans Matter; Guenther Mueller; Martin Bossart


Archive | 2003

Pyridazinone derivatives as cdk2-inhibitors

Swen Hoelder; Thorsten Naumann; Karl Schoenafinger; David William Will; Hans Matter; Guenter Mueller; Suisse Dominique Le; Bernard Baudoin; Thomas Rooney; Franck Halley; Gilles Tiraboschi; Cécile Combeau; Ingrid Sassoon; Anke Steinmetz


Archive | 2001

Substituted and unsubstituted benzooxathiazoles and compounds derived therefrom

Stefan Petry; Karl-Heinz Baringhaus; Swen Hoelder; Guenther Mueller


Archive | 2005

Novel 4-benzimidazol-2-ylpyridazin-3-one derivatives

Swen Hoelder; Karl Schoenafinger; David William Will; Hans Matter; Günter Müller; Cécile Combeau; Christine Delaisi; Anke Steinmetz; Ingrid Sassoon


Archive | 2002

New 4-(carboxamido or acylamino)-6-(hetero)aryl-pyridazinone derivatives are tau-protein phosphorylation inhibitors useful e.g. for treating neurodegenerative diseases, diabetes, hypertension or cancer

Dominique Lesuisse; Franck Halley; Bernard Baudoin; Thomas Rooney; Swen Hoelder; Thorsten Naumann; Gilles Tiraboschi


Archive | 2005

Novel pyridazinone derivatives as inhibitors of cdk2

Swen Hoelder; Guenter Mueller; Karl Schoenafinger; David William Will; Hans Matter; Bossart; Cécile Combeau; Christine Delaisi; Sassoon; Anke Steinmetz; Didier. Bernard


Archive | 2009

Pyridazinone kinase inhibitors

Swen Hoelder; Günter Müller; Karl Schoenafinger; David William Will; Hans Matter; Martin Bossart; Cécile Combeau; Christine Delaisi; Ingrid Sassoon; Anke Steinmetz; Didier Benard


Archive | 2009

Novel Pyridazinone Derivatives

Swen Hoelder; Günter Müller; Karl Schoenafinger; David William Will; Hans Matter; Martin Bossart; Cécile Combeau; Christine Delaisi; Ingrid Sassoon; Anke Steinmetz; Didier Benard


Archive | 2006

4-benzimidazol-2-ylpyridazin-3-one derivatives

Swen Hoelder; Karl Schoenafinger; David William Will; Hans Matter; Günter Müller; Cécile Combeau; Christine Delaisi; Anke Steinmetz; Ingrid Sassoon

Collaboration


Dive into the Swen Hoelder's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge